Characterization of Enterococcus faecium E86 bacteriocins and their inhibition properties against Listeria monocytogenes and vancomycin-resistant Enterococcus

Braz J Microbiol. 2021 Sep;52(3):1513-1522. doi: 10.1007/s42770-021-00494-3. Epub 2021 Apr 26.

Abstract

In the present scenario of a major demand for new compounds with antimicrobial activity, bacteriocin and bacteriocin-like inhibitory substances (BLIS) are promising tools against deteriorating and pathogenic microorganisms, thus having potential applications in both the food industry and infectious disease control. In the present report, we describe the genetic and phenotypic characteristics of BLIS produced by Enterococcus faecium E86, a strain previously isolated and sequenced by our group, focusing on the structural genes of two bacteriocins identified: enterocin TW21 and enterocin P. Transcription of all four genes associated with the biosynthesis and immunity of enterocin P and enterocin TW21 were confirmed by RT-PCR. However, Sanger sequencing confirmed a truncation of the structural gene of enterocin TW21 due to one base pair deletion (A/T). Thus, although E. faecium E86 was shown to carry two bacteriocinogenic gene clusters, only one cluster encodes a functional bacteriocin, enterocin P. Enterocin P was able to inhibit different strains of Listeria monocytogenes and vancomycin-resistant enterococci (both Enterococcus faecalis and Enterococcus faecium), showing intense bacteriolytic activity, in most cases.

Keywords: Bacteriocin; Enterocin P; Inhibitory activity; Listeria monocytogenes; VRE.

MeSH terms

  • Bacteriocins* / genetics
  • Bacteriocins* / pharmacology
  • Enterococcus faecium* / genetics
  • Listeria monocytogenes* / drug effects
  • Vancomycin
  • Vancomycin-Resistant Enterococci* / drug effects

Substances

  • Bacteriocins
  • Vancomycin